FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2152777881> ?p ?o ?g. }

• W2152777881 endingPage "1135" @default.
• W2152777881 startingPage "1125" @default.
• W2152777881 abstract "To report the results and corresponding acute and late reactions of a prospective, randomized, clinical study in locally advanced head and neck cancer comparing concurrent fluorouracil (FU) and mitomycin (MMC) chemotherapy and hyperfractionated accelerated radiation therapy (C-HART; 70.6 Gy) to hyperfractionated accelerated radiation therapy alone (HART; 77.6 Gy).Three hundred eighty-four stage III (6%) and IV (94%) oropharyngeal (59.4%), hypopharyngeal (32.3%), and oral cavity (8.3%) cancer patients were randomly assigned to receive either 30 Gy (2 Gy every day) followed by 1.4 Gy bid to a total of 70.6 Gy concurrently with FU (600 mg/m(2), 120 hours continuous infusion) days 1 through 5 and MMC (10 mg/m(2)) on days 5 and 36 (C-HART) or 14 Gy (2 Gy every day) followed by 1.4 Gy bid to a total dose of 77.6 Gy (HART). The data were analyzed on an intent-to-treat basis.At 5 years, the locoregional control and overall survival rates were 49.9% and 28.6% for C-HART versus 37.4% and 23.7% for HART, respectively (P = .001 and P = .023, respectively). Progression-free and freedom from metastases rates were 29.3% and 51.9% for C-HART versus 26.6% and 54.7% for HART, respectively (P = .009 and P = .575, respectively). For C-HART, maximum acute reactions of mucositis, moist desquamation, and erythema were lower than with HART, whereas no differences in late reactions and overall rates of secondary neoplasms were observed.C-HART (70.6 Gy) is superior to dose-escalated HART (77.6 Gy) with comparable or less acute reactions and equivalent late reactions, indicating an improvement of the therapeutic ratio." @default.
• W2152777881 created "2016-06-24" @default.
• W2152777881 creator A5012198646 @default.
• W2152777881 creator A5025926980 @default.
• W2152777881 creator A5029197290 @default.
• W2152777881 creator A5029444442 @default.
• W2152777881 creator A5046431533 @default.
• W2152777881 creator A5052874564 @default.
• W2152777881 creator A5053519063 @default.
• W2152777881 creator A5060183266 @default.
• W2152777881 creator A5062068471 @default.
• W2152777881 creator A5065855521 @default.
• W2152777881 creator A5071494218 @default.
• W2152777881 creator A5072761660 @default.
• W2152777881 creator A5073827670 @default.
• W2152777881 creator A5083101824 @default.
• W2152777881 date "2005-02-20" @default.
• W2152777881 modified "2023-10-18" @default.
• W2152777881 title "Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial" @default.
• W2152777881 cites W1784479792 @default.
• W2152777881 cites W1936206127 @default.
• W2152777881 cites W1947979503 @default.
• W2152777881 cites W1956256739 @default.
• W2152777881 cites W1968741994 @default.
• W2152777881 cites W1969169019 @default.
• W2152777881 cites W1982153752 @default.
• W2152777881 cites W1987581243 @default.
• W2152777881 cites W2013754943 @default.
• W2152777881 cites W2031505013 @default.
• W2152777881 cites W2039612753 @default.
• W2152777881 cites W2052024078 @default.
• W2152777881 cites W2059707463 @default.
• W2152777881 cites W2066660289 @default.
• W2152777881 cites W2069456446 @default.
• W2152777881 cites W2075946022 @default.
• W2152777881 cites W2083748833 @default.
• W2152777881 cites W2091203164 @default.
• W2152777881 cites W2096156091 @default.
• W2152777881 cites W2105150213 @default.
• W2152777881 cites W2126091399 @default.
• W2152777881 cites W2135574413 @default.
• W2152777881 cites W2144787357 @default.
• W2152777881 cites W2145703501 @default.
• W2152777881 cites W2146148650 @default.
• W2152777881 cites W2147292558 @default.
• W2152777881 cites W2147966099 @default.
• W2152777881 cites W2151415400 @default.
• W2152777881 cites W2152609192 @default.
• W2152777881 cites W2155019837 @default.
• W2152777881 cites W2172200669 @default.
• W2152777881 cites W2331395194 @default.
• W2152777881 cites W4299808459 @default.
• W2152777881 doi "https://doi.org/10.1200/jco.2005.07.010" @default.
• W2152777881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15718308" @default.
• W2152777881 hasPublicationYear "2005" @default.
• W2152777881 type Work @default.
• W2152777881 sameAs 2152777881 @default.
• W2152777881 citedByCount "261" @default.
• W2152777881 countsByYear W21527778812012 @default.
• W2152777881 countsByYear W21527778812013 @default.
• W2152777881 countsByYear W21527778812014 @default.
• W2152777881 countsByYear W21527778812015 @default.
• W2152777881 countsByYear W21527778812016 @default.
• W2152777881 countsByYear W21527778812017 @default.
• W2152777881 countsByYear W21527778812018 @default.
• W2152777881 countsByYear W21527778812019 @default.
• W2152777881 countsByYear W21527778812020 @default.
• W2152777881 countsByYear W21527778812021 @default.
• W2152777881 countsByYear W21527778812022 @default.
• W2152777881 countsByYear W21527778812023 @default.
• W2152777881 crossrefType "journal-article" @default.
• W2152777881 hasAuthorship W2152777881A5012198646 @default.
• W2152777881 hasAuthorship W2152777881A5025926980 @default.
• W2152777881 hasAuthorship W2152777881A5029197290 @default.
• W2152777881 hasAuthorship W2152777881A5029444442 @default.
• W2152777881 hasAuthorship W2152777881A5046431533 @default.
• W2152777881 hasAuthorship W2152777881A5052874564 @default.
• W2152777881 hasAuthorship W2152777881A5053519063 @default.
• W2152777881 hasAuthorship W2152777881A5060183266 @default.
• W2152777881 hasAuthorship W2152777881A5062068471 @default.
• W2152777881 hasAuthorship W2152777881A5065855521 @default.
• W2152777881 hasAuthorship W2152777881A5071494218 @default.
• W2152777881 hasAuthorship W2152777881A5072761660 @default.
• W2152777881 hasAuthorship W2152777881A5073827670 @default.
• W2152777881 hasAuthorship W2152777881A5083101824 @default.
• W2152777881 hasBestOaLocation W21527778811 @default.
• W2152777881 hasConcept C141071460 @default.
• W2152777881 hasConcept C155806632 @default.
• W2152777881 hasConcept C2776530083 @default.
• W2152777881 hasConcept C2776694085 @default.
• W2152777881 hasConcept C2778496288 @default.
• W2152777881 hasConcept C2779196318 @default.
• W2152777881 hasConcept C2780456651 @default.
• W2152777881 hasConcept C2908786992 @default.
• W2152777881 hasConcept C2989005 @default.
• W2152777881 hasConcept C509974204 @default.
• W2152777881 hasConcept C71924100 @default.
• W2152777881 hasConceptScore W2152777881C141071460 @default.

• next